---
title: "Expert consensus: Osteoporosis needs Vitamin D"
slug: "expert-consensus-osteoporosis-needs-vitamin-d"
aliases:
  - "/Expert+consensus+Osteoporosis+needs+Vitamin+D+–+Jan+2025"
  - "/15796"
tiki_page_id: 15796
date: 2025-01-27
---


{{< toc >}}

---

#### Expert consensus on vitamin D in osteoporosis

Sha Lei1#, Xiaoya Zhang1#, Lige Song1,2#, Jinhui Wen3, Zheng Zhang4, Jianqing Tian5, Rui Yang6, Shuhang Xu7, Shanhu Qiu8, Richard J. MacIsaac9,10, Jasna Aleksova9,11,12, Fabrice Mac-Way13, Marie-Ève Dupuis13,14, David Benaiges15,16,17,18, Didac Mauricio19, Andrei P. Sommer20, Joshua I. Barzilay21, John C. Gallagher22, Lingling Pan1, Linlin Ji1, Ping Fang1, Ying Li1, Qi Liu1, Jiasheng Zhao1, Ying Xue1, Yuqin Shen23, Lemin Wang23, Junfeng Han1,24*, Guanghui Liu1,24*

Correspondence to: Junfeng Han, MD; Guanghui Liu, MD. Department of Endocrinology and Metabolism, Tongji Hospital, School of Medicine, Tongji University, 389 Xincun Rd., Shanghai 200065, China; Diabetic Foot Center, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. Email: tjhjf@163.com; lghdoctor@126.com.

---

##### Consensus summary

| | |
| --- | --- |
| Best measurement method: serum 25<span>[OH]</span>D is identified as the optimal method for assessing vitamin D status  | level 1 evidence,  **strong recommendation**  |
| • Standardization issues: in the absence of standardized 25<span>[OH]</span>D assays, serum 25<span>[OH]</span>D levels from different clinical laboratories may not be comparable  | level 2 evidence,  **strong recommendation**  |
| • At-risk patients: measurement of serum 25<span>[OH]</span>D measurement is recommended for patients at risk of vitamin D deficiency  | level 2 evidence,  **strong recommendation**  |
| • Osteoporosis and serum levels: serum 25<span>[OH]</span>D levels should be maintained at ≥75 nmol/L in patients with osteoporosis  | level 1 evidence,  **strong recommendation**  |
| • Low-risk adults: in adults under 50 with a low risk of vitamin D insufficiency, daily supplementation exceeding 400 IU of vitamin D and 1,000 mg of calcium is not recommended  | level 1 evidence, weak recommendation |
| • Supplements for older adults: for adults over 50 at high risk of vitamin D deficiency, a minimum daily supplementation of 1,200 mg of calcium and 800 IU of vitamin D is recommended  | level 1 evidence,  **strong recommendation**  |
| • Post-supplementation testing: routine measurement of serum 25<span>[OH]</span>D within 3 months of initiating supplementation is not necessary  | level 1 evidence,  **strong recommendation**  |
| • Fracture prevention: evaluating vitamin D supplementation alone or in conjunction with calcium for primary fracture prevention in community-dwelling adults should consider the balance of potential harms and benefits  | level 1 evidence, weak recommendation |
| • Calcium and vitamin D status: adequate calcium intake and vitamin D status are essential before initiating anti-resorptive therapy in patients with vitamin D deficiency  | level 2 evidence, weak recommendation |

Background: Adequate vitamin D is essential for maintaining optimal bone health, preventing and treating of osteoporosis. However, in recent years, large clinical trials and meta-analyses on the efficacy of vitamin D supplementation to prevent fractures in populations at different risks have been equivocal. The optimal level of 25-hydroxyvitamin D (25<span>[OH]</span>D) remains controversial. Recommendations vary between societies. The lack of standardized assays also poses a challenge in interpreting available research data.

Methods: We systematically searched for articles in MEDLINE database through PubMed, which included meta-analysis, systematic reviews of randomized controlled trials (RCTs) and observational studies that assessed measurement, diagnosis and treatment about vitamin D deficiency. The experts evaluated the available literature, graded references according to the type of study and described the strength recommendations.

Results: This expert consensus is based on the review of relevant clinical evidence and provides nine key recommendations on vitamin D deficiency in populations at different risks, especially in patients with osteoporosis. Supporting information is provided in the subsequent appendix box.

Conclusions: This expert consensus is a practical tool for endocrinologists, general physicians for the diagnosis, assessment, and treatment of populations at different risks of vitamin D deficiency, especially in patients with osteoporosis. Clinicians should be aware of the evidence but make individualized decisions based on specific patients or situation.

 **<i class="fas fa-file-pdf" style="margin-right: 0.3em;"></i><a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/expert-consensus-on-vitamin-d-in-osteoporos.pdf">Download the PDF from VitaminDWiki </a>** 

---

#### See related in VitaminDWiki

* <a href="/posts/osteoporosis-treatment-vitamin-d-is-the-most-cost-effective" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Osteoporosis treatment – Vitamin D is the most cost-effective – April 2019">Osteoporosis treatment – Vitamin D is the most cost-effective – April 2019</a>

* [Osteoporosis in France can be fought with 50,000 IU of Vitamin D, weekly then bi-weekly (30-60ng) - Feb 2025](/posts/osteoporosis-in-france-can-be-fought-with-50000-iu-of-vitamin-d-weekly-then-bi-weekly-30-60ng)

   * <a href="/posts/vitamin-d-and-calcium-for-osteroporosis-in-france-increased-by-4x-2007-2016" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Vitamin D and Calcium for Osteroporosis in France increased by 4X: 2007-2016">Vitamin D and Calcium for Osteroporosis in France increased by 4X: 2007-2016</a>

* [Osteoporosis synergistically treated by bisphosphonates and Vitamin D - meta-analysis Nov 2024](/posts/osteoporosis-synergistically-treated-by-bisphosphonates-and-vitamin-d-meta-analysis)

* <a href="/posts/osteoporosis-consensus-includes-vitamin-d-and-calcium-ecuador" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Osteoporosis consensus includes Vitamin D and Calcium (Ecuador) – June 2023">Osteoporosis consensus includes Vitamin D and Calcium (Ecuador) – June 2023</a>

* <a href="/posts/hip-fractures-reduced-30-percent-with-800-iu-of-vitamin-d-meta-analysis" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Hip fractures reduced 30 percent with 800 IU of vitamin D – meta-analysis July 2012">Hip fractures reduced 30 percent with 800 IU of vitamin D – meta-analysis July 2012</a>

<!-- ~tc~ (alias(Osteoporosis needs Vitamin D and Calcium – Expert Consensus in China – Jan 2025)) ~/tc~ -->

<pre style="background-color: #e0e0e0; white-space: pre-wrap;">
<code class="language-text">
Markdown:
--------
{{&lt; toc &gt;}}

---

#### Expert consensus on vitamin D in osteoporosis

Sha Lei1#, Xiaoya Zhang1#, Lige Song1,2#, Jinhui Wen3, Zheng Zhang4, Jianqing Tian5, Rui Yang6, Shuhang Xu7, Shanhu Qiu8, Richard J. MacIsaac9,10, Jasna Aleksova9,11,12, Fabrice Mac-Way13, Marie-Ève Dupuis13,14, David Benaiges15,16,17,18, Didac Mauricio19, Andrei P. Sommer20, Joshua I. Barzilay21, John C. Gallagher22, Lingling Pan1, Linlin Ji1, Ping Fang1, Ying Li1, Qi Liu1, Jiasheng Zhao1, Ying Xue1, Yuqin Shen23, Lemin Wang23, Junfeng Han1,24*, Guanghui Liu1,24*

Correspondence to: Junfeng Han, MD; Guanghui Liu, MD. Department of Endocrinology and Metabolism, Tongji Hospital, School of Medicine, Tongji University, 389 Xincun Rd., Shanghai 200065, China; Diabetic Foot Center, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. Email: tjhjf@163.com; lghdoctor@126.com.

---

##### Consensus summary

| | |
| --- | --- |
| Best measurement method: serum 25&lt;span&gt;[OH]&lt;/span&gt;D is identified as the optimal method for assessing vitamin D status  | level 1 evidence,  **strong recommendation**  |
| • Standardization issues: in the absence of standardized 25&lt;span&gt;[OH]&lt;/span&gt;D assays, serum 25&lt;span&gt;[OH]&lt;/span&gt;D levels from different clinical laboratories may not be comparable  | level 2 evidence,  **strong recommendation**  |
| • At-risk patients: measurement of serum 25&lt;span&gt;[OH]&lt;/span&gt;D measurement is recommended for patients at risk of vitamin D deficiency  | level 2 evidence,  **strong recommendation**  |
| • Osteoporosis and serum levels: serum 25&lt;span&gt;[OH]&lt;/span&gt;D levels should be maintained at ≥75 nmol/L in patients with osteoporosis  | level 1 evidence,  **strong recommendation**  |
| • Low-risk adults: in adults under 50 with a low risk of vitamin D insufficiency, daily supplementation exceeding 400 IU of vitamin D and 1,000 mg of calcium is not recommended  | level 1 evidence, weak recommendation |
| • Supplements for older adults: for adults over 50 at high risk of vitamin D deficiency, a minimum daily supplementation of 1,200 mg of calcium and 800 IU of vitamin D is recommended  | level 1 evidence,  **strong recommendation**  |
| • Post-supplementation testing: routine measurement of serum 25&lt;span&gt;[OH]&lt;/span&gt;D within 3 months of initiating supplementation is not necessary  | level 1 evidence,  **strong recommendation**  |
| • Fracture prevention: evaluating vitamin D supplementation alone or in conjunction with calcium for primary fracture prevention in community-dwelling adults should consider the balance of potential harms and benefits  | level 1 evidence, weak recommendation |
| • Calcium and vitamin D status: adequate calcium intake and vitamin D status are essential before initiating anti-resorptive therapy in patients with vitamin D deficiency  | level 2 evidence, weak recommendation |

Background: Adequate vitamin D is essential for maintaining optimal bone health, preventing and treating of osteoporosis. However, in recent years, large clinical trials and meta-analyses on the efficacy of vitamin D supplementation to prevent fractures in populations at different risks have been equivocal. The optimal level of 25-hydroxyvitamin D (25&lt;span&gt;[OH]&lt;/span&gt;D) remains controversial. Recommendations vary between societies. The lack of standardized assays also poses a challenge in interpreting available research data.

Methods: We systematically searched for articles in MEDLINE database through PubMed, which included meta-analysis, systematic reviews of randomized controlled trials (RCTs) and observational studies that assessed measurement, diagnosis and treatment about vitamin D deficiency. The experts evaluated the available literature, graded references according to the type of study and described the strength recommendations.

Results: This expert consensus is based on the review of relevant clinical evidence and provides nine key recommendations on vitamin D deficiency in populations at different risks, especially in patients with osteoporosis. Supporting information is provided in the subsequent appendix box.

Conclusions: This expert consensus is a practical tool for endocrinologists, general physicians for the diagnosis, assessment, and treatment of populations at different risks of vitamin D deficiency, especially in patients with osteoporosis. Clinicians should be aware of the evidence but make individualized decisions based on specific patients or situation.

 **&lt;i class=&quot;fas fa-file-pdf&quot; style=&quot;margin-right: 0.3em;&quot;&gt;&lt;/i&gt;&lt;a href=&quot;https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/expert-consensus-on-vitamin-d-in-osteoporos.pdf&quot;&gt;Download the PDF from VitaminDWiki &lt;/a&gt;** 

---

#### See related in VitaminDWiki

* &lt;a href=&quot;/posts/osteoporosis-treatment-vitamin-d-is-the-most-cost-effective&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: Osteoporosis treatment – Vitamin D is the most cost-effective – April 2019&quot;&gt;Osteoporosis treatment – Vitamin D is the most cost-effective – April 2019&lt;/a&gt;

* [Osteoporosis in France can be fought with 50,000 IU of Vitamin D, weekly then bi-weekly (30-60ng) - Feb 2025](/posts/osteoporosis-in-france-can-be-fought-with-50000-iu-of-vitamin-d-weekly-then-bi-weekly-30-60ng)

   * &lt;a href=&quot;/posts/vitamin-d-and-calcium-for-osteroporosis-in-france-increased-by-4x-2007-2016&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: Vitamin D and Calcium for Osteroporosis in France increased by 4X: 2007-2016&quot;&gt;Vitamin D and Calcium for Osteroporosis in France increased by 4X: 2007-2016&lt;/a&gt;

* [Osteoporosis synergistically treated by bisphosphonates and Vitamin D - meta-analysis Nov 2024](/posts/osteoporosis-synergistically-treated-by-bisphosphonates-and-vitamin-d-meta-analysis)

* &lt;a href=&quot;/posts/osteoporosis-consensus-includes-vitamin-d-and-calcium-ecuador&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: Osteoporosis consensus includes Vitamin D and Calcium (Ecuador) – June 2023&quot;&gt;Osteoporosis consensus includes Vitamin D and Calcium (Ecuador) – June 2023&lt;/a&gt;

* &lt;a href=&quot;/posts/hip-fractures-reduced-30-percent-with-800-iu-of-vitamin-d-meta-analysis&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: Hip fractures reduced 30 percent with 800 IU of vitamin D – meta-analysis July 2012&quot;&gt;Hip fractures reduced 30 percent with 800 IU of vitamin D – meta-analysis July 2012&lt;/a&gt;

&lt;!-- ~tc~ (alias(Osteoporosis needs Vitamin D and Calcium – Expert Consensus in China – Jan 2025)) ~/tc~ --&gt;

AST Structure:
-------------
├── DivNode
│   full_match: `{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}`
│   inner_content: `{maketoc Title=&quot;&quot;}`
│   attrs_dict:
│   │   raw_content: (class=&quot;lefth4&quot;)
│   │   class: lefth4
│   children:
│   ├── MakeTocNode
│   │   full_match: `{maketoc Title=&quot;&quot;}`
│   │   inner_content: ``
│   │   attrs_dict:
│   │   │   raw_content:  Title=&quot;&quot;
│   │   │   Title: ├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!Expert consensus on vitamin D in osteoporosis`
│   inner_content: `Expert consensus on vitamin D in osteoporosis`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `Expert consensus on vitamin D in osteoporosis`
│   │   inner_content: `Expert consensus on vitamin D in osteoporosis`├── TextNode
│   full_match: `\nSha Lei1#, Xiaoya Zhang1#, Lige Song1,2#, Jinhui Wen3, Zheng Zhang4, Jianqing Tian5, Rui Yang6, Shuhang Xu7, Shanhu Qiu8, Richard J. MacIsaac9,10, Jasna Aleksova9,11,12, Fabrice Mac-Way13, Marie-Ève Dupuis13,14, David Benaiges15,16,17,18, Didac Mauricio19, Andrei P. Sommer20, Joshua I. Barzilay21, John C. Gallagher22, Lingling Pan1, Linlin Ji1, Ping Fang1, Ying Li1, Qi Liu1, Jiasheng Zhao1, Ying Xue1, Yuqin Shen23, Lemin Wang23, Junfeng Han1,24*, Guanghui Liu1,24*\nCorrespondence to: Junfeng Han, MD; Guanghui Liu, MD. Department of Endocrinology and Metabolism, Tongji Hospital, School of Medicine, Tongji University, 389 Xincun Rd., Shanghai 200065, China; Diabetic Foot Center, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. Email: tjhjf@163.com; lghdoctor@126.com.`
│   inner_content: `\nSha Lei1#, Xiaoya Zhang1#, Lige Song1,2#, Jinhui Wen3, Zheng Zhang4, Jianqing Tian5, Rui Yang6, Shuhang Xu7, Shanhu Qiu8, Richard J. MacIsaac9,10, Jasna Aleksova9,11,12, Fabrice Mac-Way13, Marie-Ève Dupuis13,14, David Benaiges15,16,17,18, Didac Mauricio19, Andrei P. Sommer20, Joshua I. Barzilay21, John C. Gallagher22, Lingling Pan1, Linlin Ji1, Ping Fang1, Ying Li1, Qi Liu1, Jiasheng Zhao1, Ying Xue1, Yuqin Shen23, Lemin Wang23, Junfeng Han1,24*, Guanghui Liu1,24*\nCorrespondence to: Junfeng Han, MD; Guanghui Liu, MD. Department of Endocrinology and Metabolism, Tongji Hospital, School of Medicine, Tongji University, 389 Xincun Rd., Shanghai 200065, China; Diabetic Foot Center, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. Email: tjhjf@163.com; lghdoctor@126.com.`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!!Consensus summary`
│   inner_content: `Consensus summary`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `Consensus summary`
│   │   inner_content: `Consensus summary`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── TableNode
│   full_match: `||Best measurement method: serum 25[OH]D is identified as the optimal method for assessing vitamin D status |level 1 evidence, __strong recommendation__\n• Standardization issues: in the absence of standardized 25[OH]D assays, serum 25[OH]D levels from different clinical laboratories may not be comparable |level 2 evidence, __strong recommendation__\n• At-risk patients: measurement of serum 25[OH]D measurement is recommended for patients at risk of vitamin D deficiency |level 2 evidence, __strong recommendation__\n• Osteoporosis and serum levels: serum 25[OH]D levels should be maintained at ≥75 nmol/L in patients with osteoporosis |level 1 evidence, __strong recommendation__\n• Low-risk adults: in adults under 50 with a low risk of vitamin D insufficiency, daily supplementation exceeding 400 IU of vitamin D and 1,000 mg of calcium is not recommended |level 1 evidence, weak recommendation\n• Supplements for older adults: for adults over 50 at high risk of vitamin D deficiency, a minimum daily supplementation of 1,200 mg of calcium and 800 IU of vitamin D is recommended |level 1 evidence, __strong recommendation__\n• Post-supplementation testing: routine measurement of serum 25[OH]D within 3 months of initiating supplementation is not necessary |level 1 evidence, __strong recommendation__\n• Fracture prevention: evaluating vitamin D supplementation alone or in conjunction with calcium for primary fracture prevention in community-dwelling adults should consider the balance of potential harms and benefits |level 1 evidence, weak recommendation\n• Calcium and vitamin D status: adequate calcium intake and vitamin D status are essential before initiating anti-resorptive therapy in patients with vitamin D deficiency |level 2 evidence, weak recommendation||`
│   inner_content: `Best measurement method: serum 25[OH]D is identified as the optimal method for assessing vitamin D status |level 1 evidence, __strong recommendation__\n• Standardization issues: in the absence of standardized 25[OH]D assays, serum 25[OH]D levels from different clinical laboratories may not be comparable |level 2 evidence, __strong recommendation__\n• At-risk patients: measurement of serum 25[OH]D measurement is recommended for patients at risk of vitamin D deficiency |level 2 evidence, __strong recommendation__\n• Osteoporosis and serum levels: serum 25[OH]D levels should be maintained at ≥75 nmol/L in patients with osteoporosis |level 1 evidence, __strong recommendation__\n• Low-risk adults: in adults under 50 with a low risk of vitamin D insufficiency, daily supplementation exceeding 400 IU of vitamin D and 1,000 mg of calcium is not recommended |level 1 evidence, weak recommendation\n• Supplements for older adults: for adults over 50 at high risk of vitamin D deficiency, a minimum daily supplementation of 1,200 mg of calcium and 800 IU of vitamin D is recommended |level 1 evidence, __strong recommendation__\n• Post-supplementation testing: routine measurement of serum 25[OH]D within 3 months of initiating supplementation is not necessary |level 1 evidence, __strong recommendation__\n• Fracture prevention: evaluating vitamin D supplementation alone or in conjunction with calcium for primary fracture prevention in community-dwelling adults should consider the balance of potential harms and benefits |level 1 evidence, weak recommendation\n• Calcium and vitamin D status: adequate calcium intake and vitamin D status are essential before initiating anti-resorptive therapy in patients with vitamin D deficiency |level 2 evidence, weak recommendation`
│   children:
│   ├── TableRowNode
│   │   full_match: `Best measurement method: serum 25[OH]D is identified as the optimal method for assessing vitamin D status |level 1 evidence, __strong recommendation__`
│   │   inner_content: `Best measurement method: serum 25[OH]D is identified as the optimal method for assessing vitamin D status |level 1 evidence, __strong recommendation__`
│   │   children:
│   │   ├── TableCellNode
│   │   │   full_match: `Best measurement method: serum 25[OH]D is identified as the optimal method for assessing vitamin D status `
│   │   │   inner_content: `Best measurement method: serum 25[OH]D is identified as the optimal method for assessing vitamin D status `
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Best measurement method: serum 25`
│   │   │   │   inner_content: `Best measurement method: serum 25`
│   │   │   ├── LinkNode
│   │   │   │   full_match: `[OH]`
│   │   │   │   inner_content: `OH`
│   │   │   │   url: `OH`
│   │   │   │   children:
│   │   │   │   ├── TextNode
│   │   │   │   │   full_match: `OH`
│   │   │   │   │   inner_content: `OH`
│   │   │   ├── TextNode
│   │   │   │   full_match: `D is identified as the optimal method for assessing vitamin D status `
│   │   │   │   inner_content: `D is identified as the optimal method for assessing vitamin D status `
│   │   ├── TableCellNode
│   │   │   full_match: `level 1 evidence, __strong recommendation__`
│   │   │   inner_content: `level 1 evidence, __strong recommendation__`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `level 1 evidence, `
│   │   │   │   inner_content: `level 1 evidence, `
│   │   │   ├── BoldNode
│   │   │   │   full_match: `__strong recommendation__`
│   │   │   │   inner_content: `strong recommendation`
│   │   │   │   children:
│   │   │   │   ├── TextNode
│   │   │   │   │   full_match: `strong recommendation`
│   │   │   │   │   inner_content: `strong recommendation`
│   ├── TableRowNode
│   │   full_match: `• Standardization issues: in the absence of standardized 25[OH]D assays, serum 25[OH]D levels from different clinical laboratories may not be comparable |level 2 evidence, __strong recommendation__`
│   │   inner_content: `• Standardization issues: in the absence of standardized 25[OH]D assays, serum 25[OH]D levels from different clinical laboratories may not be comparable |level 2 evidence, __strong recommendation__`
│   │   children:
│   │   ├── TableCellNode
│   │   │   full_match: `• Standardization issues: in the absence of standardized 25[OH]D assays, serum 25[OH]D levels from different clinical laboratories may not be comparable `
│   │   │   inner_content: `• Standardization issues: in the absence of standardized 25[OH]D assays, serum 25[OH]D levels from different clinical laboratories may not be comparable `
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `• Standardization issues: in the absence of standardized 25`
│   │   │   │   inner_content: `• Standardization issues: in the absence of standardized 25`
│   │   │   ├── LinkNode
│   │   │   │   full_match: `[OH]`
│   │   │   │   inner_content: `OH`
│   │   │   │   url: `OH`
│   │   │   │   children:
│   │   │   │   ├── TextNode
│   │   │   │   │   full_match: `OH`
│   │   │   │   │   inner_content: `OH`
│   │   │   ├── TextNode
│   │   │   │   full_match: `D assays, serum 25`
│   │   │   │   inner_content: `D assays, serum 25`
│   │   │   ├── LinkNode
│   │   │   │   full_match: `[OH]`
│   │   │   │   inner_content: `OH`
│   │   │   │   url: `OH`
│   │   │   │   children:
│   │   │   │   ├── TextNode
│   │   │   │   │   full_match: `OH`
│   │   │   │   │   inner_content: `OH`
│   │   │   ├── TextNode
│   │   │   │   full_match: `D levels from different clinical laboratories may not be comparable `
│   │   │   │   inner_content: `D levels from different clinical laboratories may not be comparable `
│   │   ├── TableCellNode
│   │   │   full_match: `level 2 evidence, __strong recommendation__`
│   │   │   inner_content: `level 2 evidence, __strong recommendation__`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `level 2 evidence, `
│   │   │   │   inner_content: `level 2 evidence, `
│   │   │   ├── BoldNode
│   │   │   │   full_match: `__strong recommendation__`
│   │   │   │   inner_content: `strong recommendation`
│   │   │   │   children:
│   │   │   │   ├── TextNode
│   │   │   │   │   full_match: `strong recommendation`
│   │   │   │   │   inner_content: `strong recommendation`
│   ├── TableRowNode
│   │   full_match: `• At-risk patients: measurement of serum 25[OH]D measurement is recommended for patients at risk of vitamin D deficiency |level 2 evidence, __strong recommendation__`
│   │   inner_content: `• At-risk patients: measurement of serum 25[OH]D measurement is recommended for patients at risk of vitamin D deficiency |level 2 evidence, __strong recommendation__`
│   │   children:
│   │   ├── TableCellNode
│   │   │   full_match: `• At-risk patients: measurement of serum 25[OH]D measurement is recommended for patients at risk of vitamin D deficiency `
│   │   │   inner_content: `• At-risk patients: measurement of serum 25[OH]D measurement is recommended for patients at risk of vitamin D deficiency `
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `• At-risk patients: measurement of serum 25`
│   │   │   │   inner_content: `• At-risk patients: measurement of serum 25`
│   │   │   ├── LinkNode
│   │   │   │   full_match: `[OH]`
│   │   │   │   inner_content: `OH`
│   │   │   │   url: `OH`
│   │   │   │   children:
│   │   │   │   ├── TextNode
│   │   │   │   │   full_match: `OH`
│   │   │   │   │   inner_content: `OH`
│   │   │   ├── TextNode
│   │   │   │   full_match: `D measurement is recommended for patients at risk of vitamin D deficiency `
│   │   │   │   inner_content: `D measurement is recommended for patients at risk of vitamin D deficiency `
│   │   ├── TableCellNode
│   │   │   full_match: `level 2 evidence, __strong recommendation__`
│   │   │   inner_content: `level 2 evidence, __strong recommendation__`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `level 2 evidence, `
│   │   │   │   inner_content: `level 2 evidence, `
│   │   │   ├── BoldNode
│   │   │   │   full_match: `__strong recommendation__`
│   │   │   │   inner_content: `strong recommendation`
│   │   │   │   children:
│   │   │   │   ├── TextNode
│   │   │   │   │   full_match: `strong recommendation`
│   │   │   │   │   inner_content: `strong recommendation`
│   ├── TableRowNode
│   │   full_match: `• Osteoporosis and serum levels: serum 25[OH]D levels should be maintained at ≥75 nmol/L in patients with osteoporosis |level 1 evidence, __strong recommendation__`
│   │   inner_content: `• Osteoporosis and serum levels: serum 25[OH]D levels should be maintained at ≥75 nmol/L in patients with osteoporosis |level 1 evidence, __strong recommendation__`
│   │   children:
│   │   ├── TableCellNode
│   │   │   full_match: `• Osteoporosis and serum levels: serum 25[OH]D levels should be maintained at ≥75 nmol/L in patients with osteoporosis `
│   │   │   inner_content: `• Osteoporosis and serum levels: serum 25[OH]D levels should be maintained at ≥75 nmol/L in patients with osteoporosis `
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `• Osteoporosis and serum levels: serum 25`
│   │   │   │   inner_content: `• Osteoporosis and serum levels: serum 25`
│   │   │   ├── LinkNode
│   │   │   │   full_match: `[OH]`
│   │   │   │   inner_content: `OH`
│   │   │   │   url: `OH`
│   │   │   │   children:
│   │   │   │   ├── TextNode
│   │   │   │   │   full_match: `OH`
│   │   │   │   │   inner_content: `OH`
│   │   │   ├── TextNode
│   │   │   │   full_match: `D levels should be maintained at ≥75 nmol/L in patients with osteoporosis `
│   │   │   │   inner_content: `D levels should be maintained at ≥75 nmol/L in patients with osteoporosis `
│   │   ├── TableCellNode
│   │   │   full_match: `level 1 evidence, __strong recommendation__`
│   │   │   inner_content: `level 1 evidence, __strong recommendation__`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `level 1 evidence, `
│   │   │   │   inner_content: `level 1 evidence, `
│   │   │   ├── BoldNode
│   │   │   │   full_match: `__strong recommendation__`
│   │   │   │   inner_content: `strong recommendation`
│   │   │   │   children:
│   │   │   │   ├── TextNode
│   │   │   │   │   full_match: `strong recommendation`
│   │   │   │   │   inner_content: `strong recommendation`
│   ├── TableRowNode
│   │   full_match: `• Low-risk adults: in adults under 50 with a low risk of vitamin D insufficiency, daily supplementation exceeding 400 IU of vitamin D and 1,000 mg of calcium is not recommended |level 1 evidence, weak recommendation`
│   │   inner_content: `• Low-risk adults: in adults under 50 with a low risk of vitamin D insufficiency, daily supplementation exceeding 400 IU of vitamin D and 1,000 mg of calcium is not recommended |level 1 evidence, weak recommendation`
│   │   children:
│   │   ├── TableCellNode
│   │   │   full_match: `• Low-risk adults: in adults under 50 with a low risk of vitamin D insufficiency, daily supplementation exceeding 400 IU of vitamin D and 1,000 mg of calcium is not recommended `
│   │   │   inner_content: `• Low-risk adults: in adults under 50 with a low risk of vitamin D insufficiency, daily supplementation exceeding 400 IU of vitamin D and 1,000 mg of calcium is not recommended `
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `• Low-risk adults: in adults under 50 with a low risk of vitamin D insufficiency, daily supplementation exceeding 400 IU of vitamin D and 1,000 mg of calcium is not recommended `
│   │   │   │   inner_content: `• Low-risk adults: in adults under 50 with a low risk of vitamin D insufficiency, daily supplementation exceeding 400 IU of vitamin D and 1,000 mg of calcium is not recommended `
│   │   ├── TableCellNode
│   │   │   full_match: `level 1 evidence, weak recommendation`
│   │   │   inner_content: `level 1 evidence, weak recommendation`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `level 1 evidence, weak recommendation`
│   │   │   │   inner_content: `level 1 evidence, weak recommendation`
│   ├── TableRowNode
│   │   full_match: `• Supplements for older adults: for adults over 50 at high risk of vitamin D deficiency, a minimum daily supplementation of 1,200 mg of calcium and 800 IU of vitamin D is recommended |level 1 evidence, __strong recommendation__`
│   │   inner_content: `• Supplements for older adults: for adults over 50 at high risk of vitamin D deficiency, a minimum daily supplementation of 1,200 mg of calcium and 800 IU of vitamin D is recommended |level 1 evidence, __strong recommendation__`
│   │   children:
│   │   ├── TableCellNode
│   │   │   full_match: `• Supplements for older adults: for adults over 50 at high risk of vitamin D deficiency, a minimum daily supplementation of 1,200 mg of calcium and 800 IU of vitamin D is recommended `
│   │   │   inner_content: `• Supplements for older adults: for adults over 50 at high risk of vitamin D deficiency, a minimum daily supplementation of 1,200 mg of calcium and 800 IU of vitamin D is recommended `
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `• Supplements for older adults: for adults over 50 at high risk of vitamin D deficiency, a minimum daily supplementation of 1,200 mg of calcium and 800 IU of vitamin D is recommended `
│   │   │   │   inner_content: `• Supplements for older adults: for adults over 50 at high risk of vitamin D deficiency, a minimum daily supplementation of 1,200 mg of calcium and 800 IU of vitamin D is recommended `
│   │   ├── TableCellNode
│   │   │   full_match: `level 1 evidence, __strong recommendation__`
│   │   │   inner_content: `level 1 evidence, __strong recommendation__`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `level 1 evidence, `
│   │   │   │   inner_content: `level 1 evidence, `
│   │   │   ├── BoldNode
│   │   │   │   full_match: `__strong recommendation__`
│   │   │   │   inner_content: `strong recommendation`
│   │   │   │   children:
│   │   │   │   ├── TextNode
│   │   │   │   │   full_match: `strong recommendation`
│   │   │   │   │   inner_content: `strong recommendation`
│   ├── TableRowNode
│   │   full_match: `• Post-supplementation testing: routine measurement of serum 25[OH]D within 3 months of initiating supplementation is not necessary |level 1 evidence, __strong recommendation__`
│   │   inner_content: `• Post-supplementation testing: routine measurement of serum 25[OH]D within 3 months of initiating supplementation is not necessary |level 1 evidence, __strong recommendation__`
│   │   children:
│   │   ├── TableCellNode
│   │   │   full_match: `• Post-supplementation testing: routine measurement of serum 25[OH]D within 3 months of initiating supplementation is not necessary `
│   │   │   inner_content: `• Post-supplementation testing: routine measurement of serum 25[OH]D within 3 months of initiating supplementation is not necessary `
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `• Post-supplementation testing: routine measurement of serum 25`
│   │   │   │   inner_content: `• Post-supplementation testing: routine measurement of serum 25`
│   │   │   ├── LinkNode
│   │   │   │   full_match: `[OH]`
│   │   │   │   inner_content: `OH`
│   │   │   │   url: `OH`
│   │   │   │   children:
│   │   │   │   ├── TextNode
│   │   │   │   │   full_match: `OH`
│   │   │   │   │   inner_content: `OH`
│   │   │   ├── TextNode
│   │   │   │   full_match: `D within 3 months of initiating supplementation is not necessary `
│   │   │   │   inner_content: `D within 3 months of initiating supplementation is not necessary `
│   │   ├── TableCellNode
│   │   │   full_match: `level 1 evidence, __strong recommendation__`
│   │   │   inner_content: `level 1 evidence, __strong recommendation__`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `level 1 evidence, `
│   │   │   │   inner_content: `level 1 evidence, `
│   │   │   ├── BoldNode
│   │   │   │   full_match: `__strong recommendation__`
│   │   │   │   inner_content: `strong recommendation`
│   │   │   │   children:
│   │   │   │   ├── TextNode
│   │   │   │   │   full_match: `strong recommendation`
│   │   │   │   │   inner_content: `strong recommendation`
│   ├── TableRowNode
│   │   full_match: `• Fracture prevention: evaluating vitamin D supplementation alone or in conjunction with calcium for primary fracture prevention in community-dwelling adults should consider the balance of potential harms and benefits |level 1 evidence, weak recommendation`
│   │   inner_content: `• Fracture prevention: evaluating vitamin D supplementation alone or in conjunction with calcium for primary fracture prevention in community-dwelling adults should consider the balance of potential harms and benefits |level 1 evidence, weak recommendation`
│   │   children:
│   │   ├── TableCellNode
│   │   │   full_match: `• Fracture prevention: evaluating vitamin D supplementation alone or in conjunction with calcium for primary fracture prevention in community-dwelling adults should consider the balance of potential harms and benefits `
│   │   │   inner_content: `• Fracture prevention: evaluating vitamin D supplementation alone or in conjunction with calcium for primary fracture prevention in community-dwelling adults should consider the balance of potential harms and benefits `
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `• Fracture prevention: evaluating vitamin D supplementation alone or in conjunction with calcium for primary fracture prevention in community-dwelling adults should consider the balance of potential harms and benefits `
│   │   │   │   inner_content: `• Fracture prevention: evaluating vitamin D supplementation alone or in conjunction with calcium for primary fracture prevention in community-dwelling adults should consider the balance of potential harms and benefits `
│   │   ├── TableCellNode
│   │   │   full_match: `level 1 evidence, weak recommendation`
│   │   │   inner_content: `level 1 evidence, weak recommendation`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `level 1 evidence, weak recommendation`
│   │   │   │   inner_content: `level 1 evidence, weak recommendation`
│   ├── TableRowNode
│   │   full_match: `• Calcium and vitamin D status: adequate calcium intake and vitamin D status are essential before initiating anti-resorptive therapy in patients with vitamin D deficiency |level 2 evidence, weak recommendation`
│   │   inner_content: `• Calcium and vitamin D status: adequate calcium intake and vitamin D status are essential before initiating anti-resorptive therapy in patients with vitamin D deficiency |level 2 evidence, weak recommendation`
│   │   children:
│   │   ├── TableCellNode
│   │   │   full_match: `• Calcium and vitamin D status: adequate calcium intake and vitamin D status are essential before initiating anti-resorptive therapy in patients with vitamin D deficiency `
│   │   │   inner_content: `• Calcium and vitamin D status: adequate calcium intake and vitamin D status are essential before initiating anti-resorptive therapy in patients with vitamin D deficiency `
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `• Calcium and vitamin D status: adequate calcium intake and vitamin D status are essential before initiating anti-resorptive therapy in patients with vitamin D deficiency `
│   │   │   │   inner_content: `• Calcium and vitamin D status: adequate calcium intake and vitamin D status are essential before initiating anti-resorptive therapy in patients with vitamin D deficiency `
│   │   ├── TableCellNode
│   │   │   full_match: `level 2 evidence, weak recommendation`
│   │   │   inner_content: `level 2 evidence, weak recommendation`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `level 2 evidence, weak recommendation`
│   │   │   │   inner_content: `level 2 evidence, weak recommendation`├── TextNode
│   full_match: `\n\nBackground: Adequate vitamin D is essential for maintaining optimal bone health, preventing and treating of osteoporosis. However, in recent years, large clinical trials and meta-analyses on the efficacy of vitamin D supplementation to prevent fractures in populations at different risks have been equivocal. The optimal level of 25-hydroxyvitamin D (25`
│   inner_content: `\n\nBackground: Adequate vitamin D is essential for maintaining optimal bone health, preventing and treating of osteoporosis. However, in recent years, large clinical trials and meta-analyses on the efficacy of vitamin D supplementation to prevent fractures in populations at different risks have been equivocal. The optimal level of 25-hydroxyvitamin D (25`├── LinkNode
│   full_match: `[OH]`
│   inner_content: `OH`
│   url: `OH`
│   children:
│   ├── TextNode
│   │   full_match: `OH`
│   │   inner_content: `OH`├── TextNode
│   full_match: `D) remains controversial. Recommendations vary between societies. The lack of standardized assays also poses a challenge in interpreting available research data.\n\nMethods: We systematically searched for articles in MEDLINE database through PubMed, which included meta-analysis, systematic reviews of randomized controlled trials (RCTs) and observational studies that assessed measurement, diagnosis and treatment about vitamin D deficiency. The experts evaluated the available literature, graded references according to the type of study and described the strength recommendations.\n\nResults: This expert consensus is based on the review of relevant clinical evidence and provides nine key recommendations on vitamin D deficiency in populations at different risks, especially in patients with osteoporosis. Supporting information is provided in the subsequent appendix box.\n\nConclusions: This expert consensus is a practical tool for endocrinologists, general physicians for the diagnosis, assessment, and treatment of populations at different risks of vitamin D deficiency, especially in patients with osteoporosis. Clinicians should be aware of the evidence but make individualized decisions based on specific patients or situation.\n`
│   inner_content: `D) remains controversial. Recommendations vary between societies. The lack of standardized assays also poses a challenge in interpreting available research data.\n\nMethods: We systematically searched for articles in MEDLINE database through PubMed, which included meta-analysis, systematic reviews of randomized controlled trials (RCTs) and observational studies that assessed measurement, diagnosis and treatment about vitamin D deficiency. The experts evaluated the available literature, graded references according to the type of study and described the strength recommendations.\n\nResults: This expert consensus is based on the review of relevant clinical evidence and provides nine key recommendations on vitamin D deficiency in populations at different risks, especially in patients with osteoporosis. Supporting information is provided in the subsequent appendix box.\n\nConclusions: This expert consensus is a practical tool for endocrinologists, general physicians for the diagnosis, assessment, and treatment of populations at different risks of vitamin D deficiency, especially in patients with osteoporosis. Clinicians should be aware of the evidence but make individualized decisions based on specific patients or situation.\n`├── FontNode
│   full_match: `{FONT(size=&quot;17&quot;)}__{ATTACH(inline=&quot;1&quot; id=&quot;22222&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__{FONT}`
│   inner_content: `__{ATTACH(inline=&quot;1&quot; id=&quot;22222&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__`
│   attrs_dict:
│   │   raw_content: size=&quot;17&quot;
│   │   size: 17
│   children:
│   ├── BoldNode
│   │   full_match: `__{ATTACH(inline=&quot;1&quot; id=&quot;22222&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__`
│   │   inner_content: `{ATTACH(inline=&quot;1&quot; id=&quot;22222&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}`
│   │   children:
│   │   ├── AttachNode
│   │   │   full_match: `{ATTACH(inline=&quot;1&quot; id=&quot;22222&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}`
│   │   │   inner_content: `Download the PDF from VitaminDWiki `
│   │   │   attrs_dict:
│   │   │   │   raw_content: (inline=&quot;1&quot; id=&quot;22222&quot; icon=&quot;1&quot;)
│   │   │   │   inline: 1
│   │   │   │   id: 22222
│   │   │   │   icon: 1
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Download the PDF from VitaminDWiki `
│   │   │   │   inner_content: `Download the PDF from VitaminDWiki `├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!VitaminDWiki – ((Overview Osteoporosis and vitamin D)) contains`
│   inner_content: `VitaminDWiki – ((Overview Osteoporosis and vitamin D)) contains`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `VitaminDWiki – `
│   │   inner_content: `VitaminDWiki – `
│   ├── LocalLinkNode
│   │   full_match: `((Overview Osteoporosis and vitamin D))`
│   │   inner_content: `Overview Osteoporosis and vitamin D`
│   │   page: `Overview Osteoporosis and vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Overview Osteoporosis and vitamin D`
│   │   │   inner_content: `Overview Osteoporosis and vitamin D`
│   ├── TextNode
│   │   full_match: ` contains`
│   │   inner_content: ` contains`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── IncludeNode
│   full_match: `{include page=&quot;Overview Osteoporosis and vitamin D&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  page=&quot;Overview Osteoporosis and vitamin D&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;
│   │   page: Overview Osteoporosis and vitamin D
│   │   start: ~tc~ start ~/tc~
│   │   stop: ~tc~ end ~/tc~
│   children:
│   ├── TextNode
│   │   full_match: ``
│   │   inner_content: ``├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!VitaminDWiki – ((Consensus Vitamin D)) category contains:`
│   inner_content: `VitaminDWiki – ((Consensus Vitamin D)) category contains:`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `VitaminDWiki – `
│   │   inner_content: `VitaminDWiki – `
│   ├── LocalLinkNode
│   │   full_match: `((Consensus Vitamin D))`
│   │   inner_content: `Consensus Vitamin D`
│   │   page: `Consensus Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Consensus Vitamin D`
│   │   │   inner_content: `Consensus Vitamin D`
│   ├── TextNode
│   │   full_match: ` category contains:`
│   │   inner_content: ` category contains:`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── IncludeNode
│   full_match: `{include page=&quot;Consensus Vitamin D&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  page=&quot;Consensus Vitamin D&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;
│   │   page: Consensus Vitamin D
│   │   start: ~tc~ start ~/tc~
│   │   stop: ~tc~ end ~/tc~
│   children:
│   ├── TextNode
│   │   full_match: ``
│   │   inner_content: ``├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!See related in VitaminDWiki`
│   inner_content: `See related in VitaminDWiki`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `See related in VitaminDWiki`
│   │   inner_content: `See related in VitaminDWiki`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*((Osteoporosis treatment – Vitamin D is the most cost-effective – April 2019))`
│   inner_content: `((Osteoporosis treatment – Vitamin D is the most cost-effective – April 2019))`
│   depth: `1`
│   children:
│   ├── LocalLinkNode
│   │   full_match: `((Osteoporosis treatment – Vitamin D is the most cost-effective – April 2019))`
│   │   inner_content: `Osteoporosis treatment – Vitamin D is the most cost-effective – April 2019`
│   │   page: `Osteoporosis treatment – Vitamin D is the most cost-effective – April 2019`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Osteoporosis treatment – Vitamin D is the most cost-effective – April 2019`
│   │   │   inner_content: `Osteoporosis treatment – Vitamin D is the most cost-effective – April 2019`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*((Osteoporosis in France can be fought with 50,000 IU of Vitamin D, weekly then bi-weekly (30-60ng) - Feb 2025))`
│   inner_content: `((Osteoporosis in France can be fought with 50,000 IU of Vitamin D, weekly then bi-weekly (30-60ng) - Feb 2025))`
│   depth: `1`
│   children:
│   ├── LocalLinkNode
│   │   full_match: `((Osteoporosis in France can be fought with 50,000 IU of Vitamin D, weekly then bi-weekly (30-60ng) - Feb 2025))`
│   │   inner_content: `Osteoporosis in France can be fought with 50,000 IU of Vitamin D, weekly then bi-weekly (30-60ng) - Feb 2025`
│   │   page: `Osteoporosis in France can be fought with 50,000 IU of Vitamin D, weekly then bi-weekly (30-60ng) - Feb 2025`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Osteoporosis in France can be fought with 50,000 IU of Vitamin D, weekly then bi-weekly (30-60ng) - Feb 2025`
│   │   │   inner_content: `Osteoporosis in France can be fought with 50,000 IU of Vitamin D, weekly then bi-weekly (30-60ng) - Feb 2025`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `**((Vitamin D and Calcium for Osteroporosis in France increased by 4X: 2007-2016))`
│   inner_content: `((Vitamin D and Calcium for Osteroporosis in France increased by 4X: 2007-2016))`
│   depth: `2`
│   children:
│   ├── LocalLinkNode
│   │   full_match: `((Vitamin D and Calcium for Osteroporosis in France increased by 4X: 2007-2016))`
│   │   inner_content: `Vitamin D and Calcium for Osteroporosis in France increased by 4X: 2007-2016`
│   │   page: `Vitamin D and Calcium for Osteroporosis in France increased by 4X: 2007-2016`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D and Calcium for Osteroporosis in France increased by 4X: 2007-2016`
│   │   │   inner_content: `Vitamin D and Calcium for Osteroporosis in France increased by 4X: 2007-2016`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*((Osteoporosis synergistically treated by bisphosphonates and Vitamin D - meta-analysis Nov 2024))`
│   inner_content: `((Osteoporosis synergistically treated by bisphosphonates and Vitamin D - meta-analysis Nov 2024))`
│   depth: `1`
│   children:
│   ├── LocalLinkNode
│   │   full_match: `((Osteoporosis synergistically treated by bisphosphonates and Vitamin D - meta-analysis Nov 2024))`
│   │   inner_content: `Osteoporosis synergistically treated by bisphosphonates and Vitamin D - meta-analysis Nov 2024`
│   │   page: `Osteoporosis synergistically treated by bisphosphonates and Vitamin D - meta-analysis Nov 2024`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Osteoporosis synergistically treated by bisphosphonates and Vitamin D - meta-analysis Nov 2024`
│   │   │   inner_content: `Osteoporosis synergistically treated by bisphosphonates and Vitamin D - meta-analysis Nov 2024`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*((Osteoporosis consensus includes Vitamin D and Calcium (Ecuador) – June 2023))`
│   inner_content: `((Osteoporosis consensus includes Vitamin D and Calcium (Ecuador) – June 2023))`
│   depth: `1`
│   children:
│   ├── LocalLinkNode
│   │   full_match: `((Osteoporosis consensus includes Vitamin D and Calcium (Ecuador) – June 2023))`
│   │   inner_content: `Osteoporosis consensus includes Vitamin D and Calcium (Ecuador) – June 2023`
│   │   page: `Osteoporosis consensus includes Vitamin D and Calcium (Ecuador) – June 2023`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Osteoporosis consensus includes Vitamin D and Calcium (Ecuador) – June 2023`
│   │   │   inner_content: `Osteoporosis consensus includes Vitamin D and Calcium (Ecuador) – June 2023`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*((Hip fractures reduced 30 percent with 800 IU of vitamin D – meta-analysis July 2012))`
│   inner_content: `((Hip fractures reduced 30 percent with 800 IU of vitamin D – meta-analysis July 2012))`
│   depth: `1`
│   children:
│   ├── LocalLinkNode
│   │   full_match: `((Hip fractures reduced 30 percent with 800 IU of vitamin D – meta-analysis July 2012))`
│   │   inner_content: `Hip fractures reduced 30 percent with 800 IU of vitamin D – meta-analysis July 2012`
│   │   page: `Hip fractures reduced 30 percent with 800 IU of vitamin D – meta-analysis July 2012`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Hip fractures reduced 30 percent with 800 IU of vitamin D – meta-analysis July 2012`
│   │   │   inner_content: `Hip fractures reduced 30 percent with 800 IU of vitamin D – meta-analysis July 2012`├── TextNode
│   full_match: `\n\n`
│   inner_content: `\n\n`├── TikiCommentNode
│   full_match: `~tc~ (alias(Osteoporosis needs Vitamin D and Calcium – Expert Consensus in China – Jan 2025)) ~/tc~`
│   inner_content: ` (alias(Osteoporosis needs Vitamin D and Calcium – Expert Consensus in China – Jan 2025)) `
│   children:
│   ├── TextNode
│   │   full_match: `(alias(Osteoporosis needs Vitamin D and Calcium – Expert Consensus in China – Jan 2025)) `
│   │   inner_content: `(alias(Osteoporosis needs Vitamin D and Calcium – Expert Consensus in China – Jan 2025)) `

Original Tiki:
-------------
{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}
---
!!!!Expert consensus on vitamin D in osteoporosis
Sha Lei1#, Xiaoya Zhang1#, Lige Song1,2#, Jinhui Wen3, Zheng Zhang4, Jianqing Tian5, Rui Yang6, Shuhang Xu7, Shanhu Qiu8, Richard J. MacIsaac9,10, Jasna Aleksova9,11,12, Fabrice Mac-Way13, Marie-Ève Dupuis13,14, David Benaiges15,16,17,18, Didac Mauricio19, Andrei P. Sommer20, Joshua I. Barzilay21, John C. Gallagher22, Lingling Pan1, Linlin Ji1, Ping Fang1, Ying Li1, Qi Liu1, Jiasheng Zhao1, Ying Xue1, Yuqin Shen23, Lemin Wang23, Junfeng Han1,24*, Guanghui Liu1,24*
Correspondence to: Junfeng Han, MD; Guanghui Liu, MD. Department of Endocrinology and Metabolism, Tongji Hospital, School of Medicine, Tongji University, 389 Xincun Rd., Shanghai 200065, China; Diabetic Foot Center, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. Email: tjhjf@163.com; lghdoctor@126.com.
---
!!!!!Consensus summary
||Best measurement method: serum 25[OH]D is identified as the optimal method for assessing vitamin D status |level 1 evidence, __strong recommendation__
• Standardization issues: in the absence of standardized 25[OH]D assays, serum 25[OH]D levels from different clinical laboratories may not be comparable |level 2 evidence, __strong recommendation__
• At-risk patients: measurement of serum 25[OH]D measurement is recommended for patients at risk of vitamin D deficiency |level 2 evidence, __strong recommendation__
• Osteoporosis and serum levels: serum 25[OH]D levels should be maintained at ≥75 nmol/L in patients with osteoporosis |level 1 evidence, __strong recommendation__
• Low-risk adults: in adults under 50 with a low risk of vitamin D insufficiency, daily supplementation exceeding 400 IU of vitamin D and 1,000 mg of calcium is not recommended |level 1 evidence, weak recommendation
• Supplements for older adults: for adults over 50 at high risk of vitamin D deficiency, a minimum daily supplementation of 1,200 mg of calcium and 800 IU of vitamin D is recommended |level 1 evidence, __strong recommendation__
• Post-supplementation testing: routine measurement of serum 25[OH]D within 3 months of initiating supplementation is not necessary |level 1 evidence, __strong recommendation__
• Fracture prevention: evaluating vitamin D supplementation alone or in conjunction with calcium for primary fracture prevention in community-dwelling adults should consider the balance of potential harms and benefits |level 1 evidence, weak recommendation
• Calcium and vitamin D status: adequate calcium intake and vitamin D status are essential before initiating anti-resorptive therapy in patients with vitamin D deficiency |level 2 evidence, weak recommendation||

Background: Adequate vitamin D is essential for maintaining optimal bone health, preventing and treating of osteoporosis. However, in recent years, large clinical trials and meta-analyses on the efficacy of vitamin D supplementation to prevent fractures in populations at different risks have been equivocal. The optimal level of 25-hydroxyvitamin D (25[OH]D) remains controversial. Recommendations vary between societies. The lack of standardized assays also poses a challenge in interpreting available research data.

Methods: We systematically searched for articles in MEDLINE database through PubMed, which included meta-analysis, systematic reviews of randomized controlled trials (RCTs) and observational studies that assessed measurement, diagnosis and treatment about vitamin D deficiency. The experts evaluated the available literature, graded references according to the type of study and described the strength recommendations.

Results: This expert consensus is based on the review of relevant clinical evidence and provides nine key recommendations on vitamin D deficiency in populations at different risks, especially in patients with osteoporosis. Supporting information is provided in the subsequent appendix box.

Conclusions: This expert consensus is a practical tool for endocrinologists, general physicians for the diagnosis, assessment, and treatment of populations at different risks of vitamin D deficiency, especially in patients with osteoporosis. Clinicians should be aware of the evidence but make individualized decisions based on specific patients or situation.
{FONT(size=&quot;17&quot;)}__{ATTACH(inline=&quot;1&quot; id=&quot;22222&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__{FONT}
---
!!!!VitaminDWiki – ((Overview Osteoporosis and vitamin D)) contains
{include page=&quot;Overview Osteoporosis and vitamin D&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}
---
!!!!VitaminDWiki – ((Consensus Vitamin D)) category contains:
{include page=&quot;Consensus Vitamin D&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}
---
!!!!See related in VitaminDWiki
*((Osteoporosis treatment – Vitamin D is the most cost-effective – April 2019))
*((Osteoporosis in France can be fought with 50,000 IU of Vitamin D, weekly then bi-weekly (30-60ng) - Feb 2025))
**((Vitamin D and Calcium for Osteroporosis in France increased by 4X: 2007-2016))
*((Osteoporosis synergistically treated by bisphosphonates and Vitamin D - meta-analysis Nov 2024))
*((Osteoporosis consensus includes Vitamin D and Calcium (Ecuador) – June 2023))
*((Hip fractures reduced 30 percent with 800 IU of vitamin D – meta-analysis July 2012))

~tc~ (alias(Osteoporosis needs Vitamin D and Calcium – Expert Consensus in China – Jan 2025)) ~/tc~
</code>
</pre>
